dataset,datim_dataelement,shortname,code,dataelement,dataelementuid,dataelementdesc,categoryoptioncombo,categoryoptioncombocode,categoryoptioncombouid,Keycode,period,orgunitlevel2,orgunitlevel3,dhis_organisationunitid,dhis_organisationunitname,datim_organisationunitid,datim_organisationunitname,value
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,135.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,113.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,156.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,193.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,113.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,192.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",FujzW8ejTb6,FujzW8ejTb6,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,427.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,1522.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,444.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,537.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,3838.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,1215.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,1939.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,1704.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,412.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,1090.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,567.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,676.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,727.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,934.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,1589.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,493.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,863.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,449.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,371.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,333.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,668.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,1046.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,675.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,434.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,285.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,285.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,462.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,361.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,2957.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,491.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,501.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,802.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,1077.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,553.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,672.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,1807.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,658.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,749.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,536.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,634.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,1812.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,564.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,261.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,599.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,428.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,496.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,948.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,832.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,673.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,296.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,1126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,412.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,784.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,508.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,658.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,309.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,2052.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,337.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,612.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,420.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,487.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,1703.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,716.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,2681.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,441.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,1097.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,2380.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,349.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,565.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,1476.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,453.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,375.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,2547.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,587.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,780.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,1469.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,1603.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,595.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,320.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,696.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,1208.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,3520.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,5223.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,3313.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,3849.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,1159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,417.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,1989.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,927.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,274.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,641.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,3040.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,525.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,1025.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,381.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,632.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,1342.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,1573.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,2751.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,135.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,405.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,999.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,181.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,269.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,651.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,4336.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,287.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",398.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,894.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,3172.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,848.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,3989.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,1277.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,207.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,1133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,862.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,4583.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,3215.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,992.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,243.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,296.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,1859.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,352.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,688.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,172.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,725.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,1076.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,978.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,2793.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,442.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,341.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,1084.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,464.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,689.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,431.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,929.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,375.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,527.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,978.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,381.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,1241.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,1050.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,664.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",zis92j8IxWw,zis92j8IxWw,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,746.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - 6 or more months, Positive",BI8xcqAAUG5,BI8xcqAAUG5,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,2193.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,2498.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,1422.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,1388.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,3092.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,1498.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,1273.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,1278.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,2569.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,1976.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,3671.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,890.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,840.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,661.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,1381.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,1059.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,1423.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,2630.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,1829.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,596.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,580.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,1100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,1131.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,578.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - 6 or more months, Positive",oEwZb35vkK8,oEwZb35vkK8,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,141.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Female, ARV Dispensing Quantity - Less than 3 months, Positive",nyOuOyIWz1j,nyOuOyIWz1j,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,459.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,330.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,1693.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,292.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,944.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,1049.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,797.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,221.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,1150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,234.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,332.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,632.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,119.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,179.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,349.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,312.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,455.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,229.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,754.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,121.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,185.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,884.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,471.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,385.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,251.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,180.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,444.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,130.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,839.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,301.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,229.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,195.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,216.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,494.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,985.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,195.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,274.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,237.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,264.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,239.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,469.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,294.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,1416.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,204.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,772.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,156.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,493.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,110.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,422.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,185.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,517.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,569.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,1134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,203.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,469.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,291.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,793.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,1202.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,734.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,738.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,211.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,110.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,440.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,298.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,1282.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,196.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,184.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,249.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,130.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,570.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,716.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,171.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,1039.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,172.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,231.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,924.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",196.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,245.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,247.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,495.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,1117.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,1007.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,883.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,1810.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,987.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,1003.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,270.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,293.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,270.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,353.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,360.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,582.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,762.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,158.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,156.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,442.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,183.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,193.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,225.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,502.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,226.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,253.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,249.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,160.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,210.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,385.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Female, ARV Dispensing Quantity - Less than 3 months, Positive",DIHSb7sDAdx,DIHSb7sDAdx,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,569.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,142.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,169.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,162.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",LavQWaDxw65,LavQWaDxw65,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,334.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,1000.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,287.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,321.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,2220.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,809.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,1143.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,1104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,346.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,692.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,332.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,454.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,385.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,584.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,854.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,330.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,399.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,247.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,207.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,215.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,265.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,794.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,312.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,309.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,194.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,176.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,334.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,222.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,1585.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,300.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,274.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,414.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,595.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,323.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,428.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,994.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,588.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,504.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,361.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,484.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,288.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,967.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,334.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,153.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,501.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,254.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,469.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,640.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,711.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,345.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,411.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,249.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,358.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,279.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,254.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,145.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,906.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,229.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,362.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,269.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,207.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,858.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,365.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,1559.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,251.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,561.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,1228.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,176.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,317.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,883.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,237.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,164.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,1236.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,287.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,388.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,713.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,977.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,328.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,154.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,463.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,478.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,1644.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,2867.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,1697.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,2338.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,470.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,233.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,1055.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,425.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,243.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,436.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,2491.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,296.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,515.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,275.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,253.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,562.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,907.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,1378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,164.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,435.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,172.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,293.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,2565.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,121.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,1559.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,437.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,2164.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,587.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,135.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,501.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,513.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,2575.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,1905.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,457.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,221.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,1107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,248.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,409.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,509.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,371.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,481.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,1492.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,285.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,250.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,649.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,338.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,357.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,225.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,467.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,299.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,221.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,299.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,532.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,257.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,529.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,750.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,276.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,202.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",rsmnUja7gKQ,rsmnUja7gKQ,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,424.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - 6 or more months, Positive",xiN0MnMoX6X,xiN0MnMoX6X,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,1232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,1418.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,844.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,757.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,1888.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,1021.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,634.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,662.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,1194.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,893.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,2418.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,414.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,390.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,418.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,609.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,473.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,749.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,1242.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,970.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,305.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,340.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,582.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,553.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,265.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - 6 or more months, Positive",mYjRxV1Tcpr,mYjRxV1Tcpr,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | <15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"<15, Male, ARV Dispensing Quantity - Less than 3 months, Positive",KBabS6dmzeX,KBabS6dmzeX,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,147.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,501.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,331.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,339.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,244.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,701.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,162.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,149.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,259.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,488.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,184.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,160.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,253.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,162.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,365.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,526.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,247.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,274.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,509.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,215.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,321.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,518.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,371.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,252.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,699.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,179.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,214.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,217.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,411.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,248.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,297.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,397.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,429.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,688.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,298.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,311.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,209.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,176.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,185.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,161.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | 15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"15+, Male, ARV Dispensing Quantity - Less than 3 months, Positive",lPz9wTFy34l,lPz9wTFy34l,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,205.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 3 to 5 months, Positive",QtSXSnPicKY,QtSXSnPicKY,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - 6 or more months, Positive",LazyMB7eea7,LazyMB7eea7,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, ARV Dispensing Quantity - Less than 3 months, Positive",BWf3mQgRMeD,BWf3mQgRMeD,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 3 to 5 months, Positive",kCz2iFCJFqs,kCz2iFCJFqs,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - 6 or more months, Positive",UJ4ao4PCPPo,UJ4ao4PCPPo,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/ARVDispense/HIVStatus)",TX_CURR_N_DSD_Age_Sex_ARVDispense_HIVStatus,"echo_TX_CURR_N_Age_Sex_ARVDispense_HIVStatus | Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",TjPwm5FAwoE,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, ARV Dispensing Quantity - Less than 3 months, Positive",e1DzVnz7pzv,e1DzVnz7pzv,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Female, Positive",AG0milXShQM,AG0milXShQM,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 10-14, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"10-14, Male, Positive",tEMe0224zlP,tEMe0224zlP,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Female, Positive",dRjezxQktoz,dRjezxQktoz,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 1-4, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"1-4, Male, Positive",jjUGfPF0ObP,jjUGfPF0ObP,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,110.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,216.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,121.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Female, Positive",QqlHrg6f0Sm,QqlHrg6f0Sm,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 15-19, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"15-19, Male, Positive",LpnJL4zZxRH,LpnJL4zZxRH,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Female, Positive",OMVFa98P0Yg,OMVFa98P0Yg,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | <1, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"<1, Male, Positive",GnpJeq2XENE,GnpJeq2XENE,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,186.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,786.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,209.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,496.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,472.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,199.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,170.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,123.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,388.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,187.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,207.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,418.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,138.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,305.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,231.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,278.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,221.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,200.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,210.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,475.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,176.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,484.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,245.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,382.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,249.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,330.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,382.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,360.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,823.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,460.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,372.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,143.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,280.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,199.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,138.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,554.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,173.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,119.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,185.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,193.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,384.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,347.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,669.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,360.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,194.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,633.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,239.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,225.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,422.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,751.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,414.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,157.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,237.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,238.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,201.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,732.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,186.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,287.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,146.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Female, Positive",LyXZybq6Sjf,LyXZybq6Sjf,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,206.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,198.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,130.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 20-24, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"20-24, Male, Positive",NCnIv37EwU1,NCnIv37EwU1,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,443.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,1584.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,339.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,1105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,844.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,495.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,382.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,244.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,254.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,870.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,271.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,223.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,295.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,119.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,113.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,691.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,131.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,197.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,400.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,497.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,187.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,450.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,209.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,165.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,239.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,471.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,203.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,157.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,140.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,169.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,223.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,361.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,131.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,350.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,142.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,422.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,155.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,953.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,665.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,165.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,425.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,586.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,288.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,472.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,740.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,158.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,341.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,867.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,1720.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,991.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,834.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,328.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,598.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,341.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,163.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,1224.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,132.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,274.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,117.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,181.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,306.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,450.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,900.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,148.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,625.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,210.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,1419.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",163.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,296.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,669.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,339.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,1221.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,427.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,469.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,763.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,1455.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,925.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,169.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,431.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,301.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,387.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,409.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,1171.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,145.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,116.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,360.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,154.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,138.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,435.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,143.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,237.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,283.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,163.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Female, Positive",zqARzn2wVj5,zqARzn2wVj5,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,303.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,142.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,377.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,282.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,234.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,183.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,156.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,206.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,187.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,117.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,182.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,160.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,476.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,251.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,162.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,559.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,201.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,110.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,373.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,146.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,243.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,373.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,215.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,275.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 25-29, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"25-29, Male, Positive",y9LP85d8t4b,y9LP85d8t4b,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,162.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,448.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,1707.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,360.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,1067.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,866.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,698.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,390.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,250.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,286.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,1119.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,147.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,226.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,213.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,186.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,264.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,789.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,116.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,193.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,403.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,526.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,201.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,511.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,189.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,184.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,172.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,307.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,567.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,157.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,140.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,181.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,213.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,145.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,417.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,160.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,132.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,141.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,474.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,165.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,540.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,173.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,1209.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,156.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,225.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,614.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,391.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,573.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,437.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,930.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,183.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,157.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,190.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,376.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,873.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,1863.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,1188.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,940.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,343.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,140.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,595.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,295.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,156.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,1474.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,146.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,222.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,333.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,466.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,871.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,145.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,678.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,211.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,1431.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,285.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,763.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,305.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,1325.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,470.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,484.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,913.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,1817.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,1150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,248.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,481.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,370.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,472.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,574.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,1000.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,343.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,206.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,446.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,138.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,273.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,333.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,252.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,198.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Female, Positive",Vi8sd7mvZW4,Vi8sd7mvZW4,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,290.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,213.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,623.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,182.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,476.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,429.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,268.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,216.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,427.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,348.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,182.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,270.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,219.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,195.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,154.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,132.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,152.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,513.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,284.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,207.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,179.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,406.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,295.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,781.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,417.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,411.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,265.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,137.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,891.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,110.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,209.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,371.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,748.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,281.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,141.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,515.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,164.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,193.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,365.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,685.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,426.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,229.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,146.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,145.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,199.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,461.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,131.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,119.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,130.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 30-34, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"30-34, Male, Positive",YDzeLL6xf5o,YDzeLL6xf5o,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,131.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,322.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,1417.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,255.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,985.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,753.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,724.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,273.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,154.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,205.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,979.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,180.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,246.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,188.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,116.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,592.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,132.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,367.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,444.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,113.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,311.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,137.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,147.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,473.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,142.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,242.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,187.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,372.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,153.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,411.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,119.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,350.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,204.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,949.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,110.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,183.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,455.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,283.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,113.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,518.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,237.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,654.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,250.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,704.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,1640.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,1061.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,817.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,258.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,395.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,1426.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,145.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,135.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,227.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,339.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,672.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,472.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,198.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,1012.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,147.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,597.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,158.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,1087.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,469.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,355.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,735.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,1536.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,1069.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,248.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,380.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,277.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,147.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,346.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,476.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,612.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,253.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,295.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,157.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,258.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,196.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,186.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Female, Positive",hRq4baaUamW,hRq4baaUamW,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,183.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,241.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,821.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,206.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,571.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,516.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,348.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,223.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,592.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,161.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,362.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,222.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,319.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,214.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,155.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,253.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,137.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,163.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,181.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,586.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,241.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,201.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,226.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,137.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,423.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,391.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,894.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,564.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,528.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,137.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,271.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,1107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,143.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,202.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,382.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,207.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,730.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,331.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,577.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,221.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,203.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,377.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,827.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,571.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,185.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,263.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,165.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,162.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,113.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 35-39, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"35-39, Male, Positive",XcW5HWccYYZ,XcW5HWccYYZ,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,228.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,953.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,153.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,659.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,488.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,526.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,264.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,163.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,723.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,197.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,441.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,306.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,234.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,314.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,168.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,267.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,346.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,245.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,127.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,655.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,161.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,319.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,244.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,386.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,121.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,199.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,458.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,158.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,515.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,1046.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,766.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,609.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,1151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,172.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,255.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,538.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,313.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,721.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,424.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,731.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,303.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,190.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,504.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,1095.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,853.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,233.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,185.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,137.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,224.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,349.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,444.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,154.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,181.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,175.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,169.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,164.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Female, Positive",PEXIFVXGP9S,PEXIFVXGP9S,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,206.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,769.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,182.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,492.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,444.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,373.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,175.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,551.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,287.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,211.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,283.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,174.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,219.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,130.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,162.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,192.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,429.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,222.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,182.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,231.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,131.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,378.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,307.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,756.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,502.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,416.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,195.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,892.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,342.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,188.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,566.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,274.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,536.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,200.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,133.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,353.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,748.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,539.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,186.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,141.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,147.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,230.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,335.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,142.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,140.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 40-44, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"40-44, Male, Positive",zouTxRQ0kXP,zouTxRQ0kXP,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,141.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,530.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,442.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,285.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,242.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,463.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,292.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,164.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,165.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,167.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,194.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,186.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,229.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,145.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,387.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,214.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,245.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,309.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,366.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,745.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,584.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,407.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,132.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,828.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,140.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,334.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,161.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,169.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,487.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,223.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,428.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,118.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,286.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,537.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,585.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,132.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,252.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,273.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,84.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,122.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,99.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,103.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,110.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Female, Positive",J8fGj3Iefbc,J8fGj3Iefbc,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,449.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,370.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,210.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,208.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,137.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,381.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,160.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,243.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,190.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,152.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,328.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,151.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,108.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,161.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,230.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,254.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,542.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,356.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,301.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,669.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,235.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,370.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,209.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,344.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,218.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,473.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,408.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,157.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,250.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 45-49, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"45-49, Male, Positive",zUjkTTlva36,zUjkTTlva36,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,299.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,252.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,165.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,159.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,300.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,117.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,167.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,111.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,141.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,267.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,130.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,227.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,434.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,353.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,212.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,512.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,224.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,327.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,147.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,264.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,171.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,343.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,404.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,190.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Female, Positive",VdMgEQkOtuV,VdMgEQkOtuV,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,289.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,213.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,152.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,270.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,141.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,123.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,104.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,93.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,178.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,117.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,64.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,167.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,165.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,344.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,261.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,217.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,480.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,134.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,234.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,192.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,286.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,306.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,168.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50-54, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50-54, Male, Positive",i1yTaswn4qW,i1yTaswn4qW,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Female, Positive",lR2zeQ9VfB8,lR2zeQ9VfB8,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 50+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"50+, Male, Positive",QwUdNwRA8Uc,QwUdNwRA8Uc,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,179.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,157.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,112.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,232.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,89.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,167.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,135.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,295.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,267.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,156.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,339.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,149.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,222.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,239.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,244.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,101.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Female, Positive",yWgBf6UOK8d,yWgBf6UOK8d,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,197.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,154.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,180.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,148.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,117.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,219.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,225.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,319.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,163.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,164.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,98.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,235.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,214.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 55-59, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"55-59, Male, Positive",N9EXA1gNh16,N9EXA1gNh16,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,85.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,71.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,56.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,87.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,57.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,88.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Female, Positive",zLbjm4E1NsG,zLbjm4E1NsG,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,44.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,113.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,58.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,73.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,46.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,83.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 5-9, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"5-9, Male, Positive",p1HABZs9ydt,p1HABZs9ydt,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,107.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,139.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,144.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,191.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,91.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,128.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,95.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,65.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,155.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Female, Positive",ay6Bp2UGIE5,ay6Bp2UGIE5,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,97.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,102.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,59.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,51.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,49.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,100.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,150.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,129.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,227.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,130.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,76.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,125.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,74.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,148.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,177.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,47.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,63.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 60-64, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"60-64, Male, Positive",lNnwcd2RT4K,lNnwcd2RT4K,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,67.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,92.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,41.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,32.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,96.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,26.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,123.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,124.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,69.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,152.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,55.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,116.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,126.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,45.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,31.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Female, Positive",YOMb0sp9VLV,YOMb0sp9VLV,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,86.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,70.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,42.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,25.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,81.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,27.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,72.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,80.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,153.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,114.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,78.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,15.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,185.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,79.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,115.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,52.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,106.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,43.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,154.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,166.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,20.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,18.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,29.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | 65+, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"65+, Male, Positive",Yy619I6uuTP,Yy619I6uuTP,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Female, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Female, Positive",GILufDV2tEB,GILufDV2tEB,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, Age/Sex/HIVStatus): Receiving ART","TX_CURR (N, DSD, Age/Sex/HIVStatus)",TX_CURR_N_DSD_Age_Sex_HIVStatus,"echo_TX_CURR_N_Age_Sex_HIVStatus | Unknown Age, Male, Positive",Hyvw9VnZ2ch,Number of adults and children currently receiving antiretroviral therapy (ART),"Unknown Age, Male, Positive",undUoo1tECg,undUoo1tECg,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,181.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,60.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,464.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,152.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,109.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,61.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,35.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,50.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,17.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,75.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,307.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,53.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,252.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,140.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,150.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,36.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,220.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,199.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,16.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,68.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,322.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,62.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,136.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,301.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,38.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,120.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,40.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,116.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,480.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,66.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,383.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,90.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,34.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,132.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,131.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,82.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,116.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,6.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | FSW, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"FSW, Positive",dUCNvz8ByrS,dUCNvz8ByrS,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,117.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,181.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,13.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,14.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,119.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,19.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,28.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,318.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,30.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,337.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,39.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,207.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,77.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,94.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,21.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,23.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | MSM, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"MSM, Positive",wbJ9Nh2jqUG,wbJ9Nh2jqUG,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,10.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,12.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,48.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,105.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,163.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,24.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,37.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,8.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,33.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,54.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,11.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,9.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,277.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | People in prisons and other enclosed settings, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"People in prisons and other enclosed settings, Positive",VCEoYHLyTxk,VCEoYHLyTxk,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201110,2023Q1,Tete,Changara,DPpYRj17uV1,CS Dzunga,X7deWPhTiIy,Dzunga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200463,2023Q1,Tete,Changara,L62WV6AxXbu,CS Changara Sede,U8feQBluEhj,Changara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200464,2023Q1,Tete,Changara,vI8pjj6mcAu,CS Missaua,ccixNtjWLkf,M'Saua  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200479,2023Q1,Tete,Changara,Toljlj09adn,CS Mazoe,nvJQYEQIFFM,Mazoe Ponte CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200494,2023Q1,Tete,Cidade de Tete,BEIqK4935Si,CS NÂº 2 ,YIxt0WtezdT,Nº 2 - Bairro Matundo CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200491,2023Q1,Tete,Cidade de Tete,CjbDec4FkeU,CS Mpadue,f0WCSs2fwvv,Mpadue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201851,2023Q1,Tete,Cidade de Tete,ris2tuYoYtW,CS NÂº 3 ,XLt8l1uPicg,Nº 3 - Bairro Manyanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200457,2023Q1,Tete,Cidade de Tete,LoiUO8sLgRA,CS NÂº 4 ,DW7NajJs9ry,Nº 4 - Bairro Muthemba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200957,2023Q1,Tete,Cidade de Tete,cXKrZBbUhrD,HP Tete,e9NQxtBNruk,Tete HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200481,2023Q1,Tete,Cidade de Tete,RxiHBnSddHb,CS NÂº 1 ,P91Rf8wCj7Z,Nº 1 - Bairro Magaia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200475,2023Q1,Tete,Mutarara,XV1d4AS1A7z,CS Inhangoma,DXrgpyCKD21,Inhangoma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201869,2023Q1,Tete,Mutarara,jrv5B2suUiV,HR Mutarara,zFzYdXMnPoP,Mutarara HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,340078,2023Q1,Tete,Moatize,GpVP3Er8tHH,CS 25 de Setembro,cGvhZR5kDxQ,25 de Setembro CS,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200471,2023Q1,Tete,Moatize,xIElA3ybQ9K,CS ZÃ³bue,dYIdx3HoWbL,Zobue CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200460,2023Q1,Tete,Moatize,K3zTWxyKzE5,CS Moatize,F42k81lXXMO,Moatize CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200472,2023Q1,Tete,Moatize,eeXvku5d78S,CS Caphirizange,dRcaKumSx2h,Caphirizange PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201698,2023Q1,Tete,Moatize,EqSs8Eh9tZl,CS CFM,pthlRKVLgNp,CFM CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200451,2023Q1,Tete,Moatize,eydYBmar8my,CS Ncondedzi,n5SZuEC3O1j,Ncondezi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200147,2023Q1,Tete,Moatize,HMVJTsa8OXT,CS Cateme,qr4pPLTe6Ki,Cateme CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200484,2023Q1,Tete,Moatize,RHvxT0kh778,CS Mameme II,DsuExtGvONG,Mameme II CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200454,2023Q1,Tete,Angonia,MfZ1FGglCMh,CS Domue,CpZyeEzz39h,Dómue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200490,2023Q1,Tete,Angonia,gkGCB2QSrvm,CS Lifidzi,MAtmMxsNpeZ,Lifidzi CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200933,2023Q1,Tete,Angonia,lO1ZOpovYiZ,HR Ulongue,sAnH4cWV41G,Ulongue HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200456,2023Q1,Tete,Angonia,sPZW2VMVI6B,CS Ulongue,gsIY3JD3iHh,Ulongue CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200447,2023Q1,Tete,Marara,hkIFBir1IrX,CS Cachembe,t0V5NCdjdPi,Cachembe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200462,2023Q1,Tete,Marara,BxkIkDAITR2,CS Boroma,dSuHNzaRaSf,Boroma CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200497,2023Q1,Manica,Barue,fDqUIAimXAL,CS Chiuala,dl9g8UYxk20,Chuala CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200549,2023Q1,Manica,Barue,GsYcZ9h9BUK,CS Nhassacara,Z6ZZLw50mAM,Nhassacara CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200521,2023Q1,Manica,Barue,d3aFvsvQ7O2,CS Nhazonia,Nv5WX50ktwr,Nhazonia CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200936,2023Q1,Manica,Barue,omMGWeMjO27,HD Catandica,qiBueINJbti,Catandica HD,5.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200530,2023Q1,Manica,Barue,XOhxRL9w3Jt,CS Honde,wgqFTVU7Iky,Honde CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200548,2023Q1,Manica,Barue,rsZpZwTAPq1,CS Cruzamento de Macossa,DVF2BNdSzV9,Cruz de Macossa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200524,2023Q1,Manica,Barue,xpFEJzy6IXt,CS Nhampassa,VSHfWQyhzUu,Nhampassa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201647,2023Q1,Tete,Cahora Bassa,IMtx8G5tq4u,HR Songo,o3nzTkLC1Pl,Songo HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200023,2023Q1,Tete,Cahora Bassa,e8wv3acHddB,CS Chitima,KCPICjUZcE4,Chitima CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200533,2023Q1,Manica,Guro,wdaQR3Yk6ji,CS Mandie,z8MwD6T43n2,Mandie CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200552,2023Q1,Manica,Guro,X8TLq4JNXju,CS Guro-Sede,VsFXXXagVmp,Guro - Sede CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200459,2023Q1,Tete,Macanga,RRFBArNZQqU,CS Furancungo,yVFdJkYsLK5,Furancungo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200452,2023Q1,Tete,Chiuta,cngCCowWdet,CS Manje,hWWRAoV26mI,Manje CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200532,2023Q1,Manica,Vanduzi,goKXBs7N5B8,CS IAC,yIcfnuZhejK,IAC CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200523,2023Q1,Manica,Vanduzi,dVMKbEosMwp,CS Matsinho,eSZjKIwHPYi,Matsinho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200564,2023Q1,Manica,Vanduzi,vtKfiT3Z1Co,CS Pungue Sul,IRD5QXalHtJ,Pungue Sul CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200565,2023Q1,Manica,Vanduzi,KImmzT8DzJ7,CS VandÃºzi,srTptJGYtcK,Vanduzi CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200542,2023Q1,Manica,Vanduzi,RZSIFguHtRn,CS Chigodore,admxsO3fTtq,Chigodole CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200503,2023Q1,Manica,Macate,JCaOI2EWde3,CS Zembe Centro,p9u7nMWHEgF,Zembe Centro CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200560,2023Q1,Manica,Macate,mNfnkeXdKxY,CS Macate,pEAFBcOJIVF,Macate CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200501,2023Q1,Manica,Macate,tkLybDtDdo0,CS Marera,t3snPDHuVBW,Marera CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201028,2023Q1,Tete,Magoe,NE3tEHxUcic,CS Daque,lUDMkJxSxHL,Daque CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200483,2023Q1,Tete,Magoe,CAszGuhyUnC,CS Mucumbura,oJNbeCd6bvb,Mucumbura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200469,2023Q1,Tete,Magoe,zo9yOvNADO0,CS Magoe,Uih0KGtvZeo,Magoe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200535,2023Q1,Manica,Machaze,Sqry0ikIChZ,CS Bassane,aUMEQzUKI0K,Bassane CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200538,2023Q1,Manica,Machaze,MdN1RqeBzCP,CS Chipodji,dZrjKdqCi1w,Chipudji CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200536,2023Q1,Manica,Machaze,e3XMm8h8pJ3,CS Chitobe,FmAQ159jI3w,Chitobe CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200539,2023Q1,Manica,Machaze,oi1t1JPUViW,CS Mavende,z8UkGdr2xNs,Mavende CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200557,2023Q1,Manica,Machaze,HZVnPphSXDJ,CS Save,ZifoCg4OvIj,Save CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200556,2023Q1,Manica,Machaze,MfZ8vUFX3fM,CS Mazwissanga,c6yCKEAemfr,Mazwissanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200561,2023Q1,Manica,Machaze,wXsyilYI7PO,CS Chipopopo,jhngb8KdYU1,Chipopopo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200566,2023Q1,Manica,Mossurize,pdtUKo1EQzR,CS Dacata,yYG52aLO1GK,Dacata CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200567,2023Q1,Manica,Mossurize,B0ndNKYIIDd,CS Mude,t0KQQSZk9rF,Mude CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200939,2023Q1,Manica,Mossurize,A4fQVrJD7Zd,HD Espungabera,ZrUjQFzR1gM,Espungabera CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201645,2023Q1,Manica,Mossurize,OFV5FvycnU2,CS Garagua,A0e3A15Lh1d,Garagua CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200032,2023Q1,Manica,Mossurize,GY2vnTIADh1,CS Chaiva,kKsL2QkNR4K,Chaiva CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200513,2023Q1,Manica,Mossurize,djm9ORhcU3X,CS Gunhe,X6efCWparbb,Gunhe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200529,2023Q1,Manica,Mossurize,U7iWzT5xo5X,CS Mupengo,NJKcpotvrAQ,Mupengo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200528,2023Q1,Manica,Manica,XUfVdKbiMwL,CS Messica,gVZ58EQOH6K,Messica CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200563,2023Q1,Manica,Manica,hPqiPGsEYv5,CS Machipanda,RiIZqF2hfqY,Machipanda CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200938,2023Q1,Manica,Manica,lT5Qs9ETV9s,HD Manica,KjMGcLd3XXd,Manica HD,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,338288,2023Q1,Manica,Manica,rfn0xX7liVL,CS 4Âº Congresso,DAcTRfO0CNG,4º Congresso CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200629,2023Q1,Sofala,Caia,wqEd97U0K52,CS Sena,XFEHZnnEGkT,Sena  CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200577,2023Q1,Sofala,Caia,p798JDcqmrc,HD Caia,vugElbQMtcL,Caia HD,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200580,2023Q1,Sofala,Caia,ARq3tEA0xTJ,CS Nhambalo,tfEtbnUgkGv,Nhambalo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200579,2023Q1,Sofala,Caia,zHiDaFKNWdi,CS MurraÃ§a,PPb3XMcCAf3,Murraça CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200657,2023Q1,Sofala,Gorongosa,iLe1dgNMg89,CS Gorongosa ,ZWAdop7zYgJ,Gorongoza-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200604,2023Q1,Sofala,Chibabava,mlOXv0OHQvf,CS Chibabava -Sede,JnsP1SLvvsw,Chibabava-Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200586,2023Q1,Sofala,Chibabava,xeRs7aXKnm2,CS Hoode,nYIBsKHueFr,Hoode PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200942,2023Q1,Sofala,Chibabava,LWmmJvxx1Gu,HR Muxungue,TWJPFfCeHES,Muxungue CS III,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,321331,2023Q1,Sofala,Chibabava,Zb6ryBo3GmN,CS Mutindire,YBG39jGSV17,Mutindire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200648,2023Q1,Sofala,Cheringoma,qBXL4ozcMHG,HR Inhaminga,d3thFMLEOGr,Inhaminga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200500,2023Q1,Manica,Gondola,JlUMz2rDy1g,CS Inchope,bifefa8JnfN,Inchope CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200937,2023Q1,Manica,Gondola,pELuhX7Rgup,CS Gondola Sede,awoAlwC06Go,Gondola Sede CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200527,2023Q1,Manica,Gondola,L7TkArEzSdW,CS Amatongas,e2cMNKCnHOw,Amatongas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200502,2023Q1,Manica,Gondola,UzFYRpkVqN2,CS Muda SerraÃ§Ã£o,xfxtwRZ7Ejp,Muda Serração CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200588,2023Q1,Sofala,Cidade da Beira,JWkHE4YUUau,CS Ceramica,i4KTQ0RGK3T,Cerâmica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200615,2023Q1,Sofala,Cidade da Beira,yVukesfhN7e,CS Chamba,hFwwNnFm1B8,Chamba PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200613,2023Q1,Sofala,Cidade da Beira,JEcWd2ZtbXW,CS Manga Mascarenha,U6Mo4GsQKwT,M. Mascarenha CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200591,2023Q1,Sofala,Cidade da Beira,bcmSNr2mpCs,CS Munhava,webeuXrveDi,Munhava CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200590,2023Q1,Sofala,Cidade da Beira,TulcwtPpnb8,CS Manga Nhaconjo,I2tQnsS7wn6,Manga Nhaconjo PS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200593,2023Q1,Sofala,Cidade da Beira,C7aNdIzrk1P,CS Macurungo,tNf8m963xKK,Macurungo PSA,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200612,2023Q1,Sofala,Cidade da Beira,AG0Ij65tpL5,CS Chota,aoY0wrz6qBF,Chota PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201658,2023Q1,Sofala,Cidade da Beira,SpwE4sMebjN,CS Marrocanhe,QxSfgx5QfT7,Marrocanhe,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201657,2023Q1,Sofala,Cidade da Beira,IOginoM10CL,CS Manga Loforte,FdqK3U8rDRX,Manga Loforte,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200616,2023Q1,Sofala,Cidade da Beira,ZQyVTqYwqi6,CS Matadoro,QTFJClMfP8c,Matadouro PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200963,2023Q1,Sofala,Cidade da Beira,UuulAHWKfk9,HC Beira,V1MbBFGqwbB,Hospital Central da Beira HC,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200592,2023Q1,Sofala,Cidade da Beira,wHarKyfDUwa,CS Nhangau,KQYxmgQNUSD,Nhangau CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200614,2023Q1,Sofala,Cidade da Beira,GJwxy5Apew7,CS Ponta Gea,ZKVzRmYkKzQ,Ponta Gêa PS,22.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200600,2023Q1,Sofala,Nhamatanda,SGBoKQCD9yI,CS Nharuchonga,lKLoN95Lufh,Nharuchonga PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200661,2023Q1,Sofala,Nhamatanda,JNpcC8Vmf7o,CS Metuchira Lomaco,lYNYlzUvgos,Metuchira Lomaco CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,321326,2023Q1,Sofala,Nhamatanda,ZEzNCIIh8B2,CS Chirassicua,vIB6Ofu2fJp,Chirassicua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200601,2023Q1,Sofala,Nhamatanda,O7hrmPQMkpC,CS Siluvo CSRII,asg9aIblmr6,Siluvo PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200643,2023Q1,Sofala,Nhamatanda,Gb6NMzoxJ9y,CS Lamego,j7218NqxjYe,Lamego CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200667,2023Q1,Sofala,Nhamatanda,TDmBoHHdXcU,CS Tica CSRII,QvQ5bpVOJDj,Tica PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200943,2023Q1,Sofala,Nhamatanda,bOa7m01wjCc,HR Nhamatanda Sede,nmdSUueCjti,Nhamatanda HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200169,2023Q1,Niassa,Cuamba,IHO6FqT2VCc,CS Mitucue,elnT3rmS6qj,Mitucué CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,360175,2023Q1,Niassa,Cuamba,L4A4cHnmqCy,CS Adine 3,WQny6fFqvYX,Adine 3 CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200192,2023Q1,Niassa,Cuamba,mY5o8jTjIKb,CS Cuamba,kdUL3XxL1bF,Cuamba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200914,2023Q1,Niassa,Cuamba,qZAR8aTw3ok,HR Cuamba,JTNDUJAu3DA,Cuamba HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200157,2023Q1,Niassa,Cuamba,uSOgQiIsgwu,CS Meripo,MzafLLW5jpx,Meripo CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200669,2023Q1,Sofala,Dondo,ZATPLvkZR0W,CS Savane,ME9FWjRMe4e,Savane PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200617,2023Q1,Sofala,Dondo,M3wyiBatqt0,CS Canhandula,TJp862VOKlS,Canhandula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200618,2023Q1,Sofala,Dondo,OOVQmzaYBir,CS Dondo Sede,uUmAJIXkmsO,Dondo Sede CS I,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200633,2023Q1,Sofala,Dondo,j0ccY4zL81U,CS Maxorote,GTQqEhUUV1F,Maxarote PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201858,2023Q1,Sofala,Dondo,t9RIGm3h8DV,CS Samora Machel,dSJcUkmJWvZ,"Samora Machel PS (Sofala, Dondo)",0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,321330,2023Q1,Sofala,Dondo,CHxnHTfZupS,CS Igreja Baptista,I6v4GYaXpQC,Igreja Baptista CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200572,2023Q1,Sofala,Dondo,QtNLat7uQMf,CS Mafambisse,hCuRPOStRLU,Mafambisse CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200655,2023Q1,Sofala,Dondo,dWJ61DAg5kn,CS Mutua,QtJyTjN5faU,Mutua PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200531,2023Q1,Manica,Cidade de Chimoio,g9AT6oQ6Uoi,CS Nhamaonha,UBe2SLdSmxV,Nhamaonha CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,398330,2023Q1,Manica,Cidade de Chimoio,lR0tDnUzHdB,CS Vila Nova,KxEa3dXzAYv,Vila Nova CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200958,2023Q1,Manica,Cidade de Chimoio,oUykqIIWuIb,HP Chimoio,QDkCAOGVng6,Chimoio HP,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200522,2023Q1,Manica,Cidade de Chimoio,aUtB6n9lhl4,CS Chissui,IJwB2CRmy7D,Chissui CS,4.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201696,2023Q1,Manica,Cidade de Chimoio,SKLMPC7qDwD,CS 7 de Abril,DfdvXXyNSoV,7 de Abril CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200525,2023Q1,Manica,Cidade de Chimoio,nT0RSdagl3c,CS Eduardo Mondlane,rlAmYWNUTnR,Eduardo Mondlane CS,2.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200499,2023Q1,Manica,Cidade de Chimoio,ZPCgEihjMiy,CS 1 Âº de Maio,l7dBO27dhA6,1º Maio CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200559,2023Q1,Manica,Sussundenga,gucAF89KSPW,CS Dombe,xf9Q4yYDlq5,Dombe CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,321333,2023Q1,Manica,Sussundenga,IVMLAFPrwB1,CS Sembezea,rnZaJL4iEBz,Sembezea CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,338290,2023Q1,Manica,Sussundenga,VE6gqvIqNNU,CS Darue,kny7mdXnSEx,Darue CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200517,2023Q1,Manica,Sussundenga,hzMMspjctBN,CS Sussundenga-Sede,RovRnV9RWFd,Sussundenga CS,7.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200546,2023Q1,Manica,Sussundenga,QAbnMAYSwNt,CS Munhinga,Kwts2m2rUUp,Munhinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200178,2023Q1,Niassa,Cidade de Lichinga,v8IcierBRV0,CS Namacula,TM31sX4CThP,Namacula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,201205,2023Q1,Niassa,Cidade de Lichinga,rA2XtLlH4ZB,CS Lulimire,Ui58kwN6uQ0,Lulimire CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200954,2023Q1,Niassa,Cidade de Lichinga,VKP8A0OwApk,HP Lichinga,SfB5NwJXaot,Lichinga HP,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200152,2023Q1,Niassa,Cidade de Lichinga,jHlNl7FzWw1,CS Chiuaula,AEZgWxwdbd9,Chiuaula PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200155,2023Q1,Niassa,Cidade de Lichinga,kTLJHJShXJC,CS Lichinga,BRlA0HkkMGM,Lichinga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200941,2023Q1,Sofala,Marromeu,zQrQsbs6EHX,HR Marromeu,RxHTSbz8VN5,Marromeu HR,3.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200599,2023Q1,Sofala,Marromeu,olAdg7i0qDZ,CS Nensa,euFWewBZ5Xr,Nensa CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200173,2023Q1,Niassa,Mecanhelas,yLGuFP6jHk4,CS Chisaua,v4ZYs2QjOQO,Chissaua CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200163,2023Q1,Niassa,Mecanhelas,TJhnk83hQLW,CS Mecanhelas,wtV2TtEPCCZ,Mecanhelas CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200165,2023Q1,Niassa,Mecanhelas,yDYqmDwiMUu,CS Entre-Lagos,aoJNeHN9JFY,Entre-Lagos CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200190,2023Q1,Niassa,Lago,pGcM8SNZ1uD,CS Metangula,DhPZWGceA1Q,Metangula CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200154,2023Q1,Niassa,Mandimba,mEd88tafLmT,CS Mitande,SufFhnSEIKA,Mitande CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200180,2023Q1,Niassa,Mandimba,KqIfEtf5mj8,CS Mandimba,GDCM1IWa7Zh,Mandimba CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200195,2023Q1,Niassa,Ngauma,i9cfzJGXjve,CS Massangulo,KujnNfVcY2N,Massangulo CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200191,2023Q1,Niassa,Metarica,uLXgeGEYPsn,CS Metarica,dQk8ubXxXLX,Metarica CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200625,2023Q1,Sofala,Buzi,BDXebOcXCzA,CS Bura,d9VvJxm3TX0,Bura CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200576,2023Q1,Sofala,Buzi,A6UC3jvbYGo,CS Guara-Guara,EQs1z4T6WiJ,Guara-Guara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200605,2023Q1,Sofala,Buzi,barctDO0AlZ,CS Ampara,VqeMGiX9sMV,Ampara PS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200574,2023Q1,Sofala,Buzi,enNmUo4i8I7,CS Bandua,XvVmyn071HT,Bandua CS,1.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200940,2023Q1,Sofala,Buzi,a4N0oupiD9t,HR Buzi Sede,QCY2lUMpt7f,Buzi Sede HR,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,200638,2023Q1,Sofala,Machanga,OovZT6YXvH2,CS Machanga ,T6VbSgxjG4o,Machanga CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,99999,2023Q1,Manica,Chimoio,kuc35LlO53Y,CS Penitenciário Cabeça do Velho,a1KCMV2VRpC,Penitenciário Cabeça do Velho CS,0.0
MER Results: Facility Based,"TX_CURR (N, DSD, KeyPop/HIVStatus): Receiving ART","TX_CURR (N, DSD, KeyPop/HIVStatus)",TX_CURR_N_DSD_KeyPop_HIVStatus,"echo_TX_CURR_N_KeyPop_HIVStatus | PWID, Positive",ScQASwweWXL,Number of adults and children currently receiving antiretroviral therapy (ART),"PWID, Positive",FyhQbdBMM1p,FyhQbdBMM1p,66666,2023Q1,Sofala,Beira,VnnwcG90OEt,CS Inhamizua,wmXdfKNX0qT,Inhamizua CS,0.0
